Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis

NCT05648734 · clinicaltrials.gov ↗
COMPLETED
Status
200
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Mansoura University